GTF3C1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.509400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.738200E-01
Normal-vs-Stage2
7.533000E-01
Normal-vs-Stage3
3.268200E-01
Normal-vs-Stage4
8.451200E-01
Stage1-vs-Stage2
9.362200E-01
Stage1-vs-Stage3
2.657600E-01
Stage1-vs-Stage4
6.151600E-01
Stage2-vs-Stage3
1.677180E-01
Stage2-vs-Stage4
5.034400E-01
Stage3-vs-Stage4
2.689800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.230600E-01
Normal-vs-AfricanAmerican
6.060000E-01
Normal-vs-Asian
6.747400E-01
Caucasian-vs-AfricanAmerican
2.503000E-01
Caucasian-vs-Asian
7.325000E-01
AfricanAmerican-vs-Asian
2.352800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.863000E-01
Normal-vs-Female
9.989000E-01
Male-vs-Female
2.158200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.149000E-01
Normal-vs-Age(41-60Yrs)
7.769600E-01
Normal-vs-Age(61-80Yrs)
7.625000E-01
Normal-vs-Age(81-100Yrs)
3.848600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.535600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.567600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.589600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.970200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.119800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.482600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.994600E-01
Normal-vs-Daily Drinker
4.289200E-01
Normal-vs-Weekly Drinker
8.636800E-01
Normal-vs-Occasional Drinker
7.943000E-01
Normal-vs-Social Drinker
7.842400E-01
Non Drinker-vs-Daily Drinker
8.510800E-01
Non Drinker-vs-Weekly Drinker
7.274100E-02
Non Drinker-vs-Occasional Drinker
1.377170E-01
Non Drinker-vs-Social Drinker
3.706100E-02
Daily Drinker-vs-Weekly Drinker
1.094640E-01
Daily Drinker-vs-Occasional Drinker
1.657980E-01
Daily Drinker-vs-Social Drinker
5.651600E-02
Weekly Drinker-vs-Occasional Drinker
7.145200E-01
Weekly Drinker-vs-Social Drinker
9.397400E-01
Occasional Drinker-vs-Social Drinker
7.350200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.756800E-01
Normal-vs-Grade 2
8.881600E-01
Normal-vs-Grade 3
8.440200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.898200E-01
Grade 1-vs-Grade 3
5.191000E-01
Grade 1-vs-Grade 4
7.756800E-01
Grade 2-vs-Grade 3
2.434600E-01
Grade 2-vs-Grade 4
8.881600E-01
Grade 3-vs-Grade 4
8.440200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.494800E-01
Normal-vs-NonDiabetic
9.363600E-01
Diabetic-vs-NonDiabetic
6.461900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.031800E-01
Normal-vs-NoPancreatitis
8.199800E-01
Pancreatitis-vs-NoPancreatitis
2.503800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.474600E-01
Normal-vs-N1
7.952000E-01
N0-vs-N1
6.918000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.202800E-01
Normal-vs-TP53-NonMutant
8.119000E-01
TP53-Mutant-vs-TP53-NonMutant
5.051200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
